Response to: Olry de Labry Lima A et al., Cost-effectiveness of lenalidomide maintenance in patients with multiple myeloma who have undergone autologous transplant hematopoietic progenitor cells
Autor: | Sujith Dhanasiri |
---|---|
Rok vydání: | 2019 |
Předmět: |
Quality of life
Oncology medicine.medical_specialty Cost effectiveness Cost-Benefit Analysis MEDLINE Myeloma Internal medicine Correspondence medicine Humans In patient Autografts Autologous transplant Lenalidomide Multiple myeloma Transplantation business.industry Hematology Hematopoietic Stem Cells medicine.disease Hematopoietic progenitor cells Multiple Myeloma business medicine.drug |
Zdroj: | Bone Marrow Transplantation |
ISSN: | 1476-5365 0268-3369 |
Databáze: | OpenAIRE |
Externí odkaz: |